The association with xerostomia from sialadenitis and the jaw osteonecrosis in head and neck cancer population: a nationwide cohort study.
Aged
Bisphosphonate-Associated Osteonecrosis of the Jaw
/ epidemiology
Bone Density Conservation Agents
/ administration & dosage
Case-Control Studies
Diphosphonates
/ administration & dosage
Female
Head and Neck Neoplasms
/ drug therapy
Humans
Incidence
Longitudinal Studies
Male
Middle Aged
Osteoradionecrosis
/ epidemiology
Radiotherapy Dosage
Risk Factors
Sialadenitis
/ complications
Taiwan
/ epidemiology
Xerostomia
/ epidemiology
Head and neck cancer
Osteonecrosis of the jaw
Osteoradionecrosis
Population-based
Radiotherapy
Sialadenitis
Journal
Clinical oral investigations
ISSN: 1436-3771
Titre abrégé: Clin Oral Investig
Pays: Germany
ID NLM: 9707115
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
28
07
2017
accepted:
19
04
2018
pubmed:
5
5
2018
medline:
14
6
2019
entrez:
5
5
2018
Statut:
ppublish
Résumé
Determine the association between sialadenitis and osteonecrosis of the jaw (ONJ) in head and neck cancer (HNC) patients with varying severity of sialadenitis, treatment modalities, and cancer locations. A total of 40,168 HNC patients, including 1907 ONJ subjects and 7559 matched comparisons, were enrolled from a Longitudinal Health Insurance Database for Catastrophic Illness Patients of Taiwan between 2000 and 2006. The association with sialadenitis and ONJ was estimated by logic regression and presented as the odds ratio (OR) and 95% confidence intervals (CIs). The occurrence of sialadenitis increased the risk of ONJ by 2.55-fold in HNC patients (95% CI = 2.20-2.95). The ONJ incidence was proportion to sialadenitis severity (OR = 2.53 to 4.43). Irradiated HNC patients had a higher tendency to develop jaw necrosis (osteoradionecrosis, ORN) (OR = 5.05, 95% CI = 4.39-5.80). When combined with irradiation exposure, sialadenitis significantly induced the occurrence of ORN (OR = 8.94, 95% CI = 7.40-10.8), especially in oral cancer patients (OR = 15.9 95% CI = 12.5-20.3). The risk of ONJ increased with radiotherapy dosage and duration, except for nasopharyngeal cancer (NPC) patients. There was a close association between sialadenitis and ONJ in the HNC population. The severity of sialadenitis was positive correlated to ONJ risk. Radiotherapy combined with sialadenitis significantly raised ORN incidence in HNC patients except for NPC patients. HNC patients complained that xerostomia from sialadenitis might increase the risk to develop ONJ, especially among those who received radiotherapy.
Identifiants
pubmed: 29725850
doi: 10.1007/s00784-018-2465-3
pii: 10.1007/s00784-018-2465-3
doi:
Substances chimiques
Bone Density Conservation Agents
0
Diphosphonates
0
Types de publication
Journal Article
Langues
eng
Pagination
585-593Subventions
Organisme : Ministry of Health and Welfare
ID : MOHW105-TDU-B-212-133019
Organisme : Academia Sinica
ID : BM10501010037
Organisme : National Research Program for Biopharmaceuticals
ID : MOST 104-2325-B-039-005
Organisme : Chang Gung Memorial Hospital, Linkou
ID : CMRPG3C1791
Organisme : Chang Gung Memorial Hospital, Linkou
ID : CMRPG3E1341
Organisme : Far Eastern Memorial Hospital
ID : FEMH-2016-C-036
Références
BMJ. 2012 Sep 10;345:e5988; author reply e5990
pubmed: 22963942
PLoS One. 2015 Apr 16;10(4):e0120756
pubmed: 25880208
J Dent Res. 2011 Nov;90(11):1339-45
pubmed: 21921248
J Bone Miner Res. 2015 Jan;30(1):3-23
pubmed: 25414052
Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):269-76
pubmed: 20100642
Mol Ther. 2007 Dec;15(12):2101-6
pubmed: 17726456
J Otolaryngol. 1981 Feb;10(1):35-40
pubmed: 7206026
Support Care Cancer. 2002 Jan;10(1):40-3
pubmed: 11777187
J Clin Periodontol. 2015 Oct;42(10):922-32
pubmed: 26362756
J Am Dent Assoc. 2009 Jul;140(7):864-75
pubmed: 19571050
J Dent Res. 2011 Apr;90(4):433-8
pubmed: 21317245
Oral Oncol. 2016 May;56:71-7
pubmed: 27086489
J Dent Res. 2012 Jul;91(7):702-8
pubmed: 22592127
Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):415-20
pubmed: 22795804
Dent Clin North Am. 2016 Jan;60(1):265-77
pubmed: 26614957
Clin Oral Investig. 2013 Nov;17(8):1839-45
pubmed: 23212125
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jun;105(6):731-8
pubmed: 18329913
J Dent Res. 2017 May;96(5):531-538
pubmed: 28095728
Oral Surg Oral Med Oral Pathol. 1987 Oct;64(4):379-90
pubmed: 3477756
J Oral Maxillofac Surg. 2012 Apr;70(4):821-9
pubmed: 21764202
Oral Oncol. 2013 Sep;49(9):878-886
pubmed: 23890929
Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Nov;124(5):464-471
pubmed: 29103566
Thyroid. 2015 Jul;25(7):834-8
pubmed: 25860842
Oral Dis. 2002 Mar;8(2):77-89
pubmed: 11991308
J Prosthet Dent. 1972 Jun;27(6):640-4
pubmed: 4503890
Otolaryngol Clin North Am. 1999 Oct;32(5):793-811
pubmed: 10477787
Periodontol 2000. 2016 Feb;70(1):11-25
pubmed: 26662479
J Dent Res. 1987 Feb;66 Spec No:648-53
pubmed: 3476629
Oral Dis. 2013 Apr;19(3):219-29
pubmed: 22994880
J Oral Maxillofac Surg. 1997 Jun;55(6):540-4; discussion 545-6
pubmed: 9191633
Gerodontology. 2003 Dec;20(2):64-77
pubmed: 14697016
J Dent Res. 1983 Sep;62(9):943-5
pubmed: 6575996
Cancer Med. 2017 Oct;6(10):2271-2277
pubmed: 28941210
Head Neck. 1999 Jan;21(1):1-11
pubmed: 9890345